SMS Lifesciences India Ltd. (HALEOSLABS) Financial Statements

1 Followers

SMS Lifesciences India Ltd. Financial Overview

SMS Lifesciences India Ltd.'s market cap is currently ₹4.46B. The company's EPS TTM is ₹21.886; its P/E ratio is 13.96; and it has a dividend yield of 0.12%. SMS Lifesciences India Ltd. is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 21
Income Statement
Total Revenue	₹ 3.37B	₹ 3.00B	₹ 3.13B	₹ 2.65B	₹ 3.47B
Gross Profit	₹ 1.17B	₹ 907.68M	₹ 845.45M	₹ 408.72M	₹ 875.42M
Operating Income	₹ 301.28M	₹ 162.84M	₹ 180.47M	₹ 246.94M	₹ 246.54M
EBITDA	₹ 496.44M	₹ 347.37M	₹ 338.06M	₹ 319.58M	₹ 484.37M
Net Income	₹ 201.09M	₹ 90.93M	₹ 114.63M	₹ 135.57M	₹ 253.22M
Balance Sheet
Cash & Short-Term Investments	₹ 15.08M	₹ 14.93M	₹ 36.10M	₹ 110.64M	₹ 33.56M
Total Assets	₹ 3.90B	₹ 3.91B	₹ 3.95B	₹ 3.05B	₹ 3.57B
Total Debt	₹ 864.09M	₹ 1.01B	₹ 1.00B	₹ 651.63M	₹ 795.98M
Net Debt	₹ 859.06M	₹ 1.00B	₹ 992.12M	₹ 561.89M	₹ 786.12M
Total Liabilities	₹ 1.78B	₹ 1.98B	₹ 2.07B	₹ 1.76B	₹ 1.92B
Stockholders' Equity	₹ 1.97B	₹ 1.77B	₹ 1.69B	₹ 1.29B	₹ 1.52B
Cash Flow
Free Cash Flow	₹ 187.06M	₹ 34.38M	₹ -338.56M	₹ -25.15M	₹ -623.94M
Operating Cash Flow	₹ 340.55M	₹ 243.06M	₹ 146.95M	₹ 330.42M	₹ -112.41M
Investing Cash Flow	₹ -149.98M	₹ -184.50M	₹ -312.92M	₹ -266.22M	₹ -71.43M
Financing Cash Flow	₹ -191.24M	₹ -65.64M	₹ 168.88M	₹ -310.00K	₹ 108.33M

Currency in INR

SMS Lifesciences India Ltd. Earnings and Revenue History

Income Statement >

SMS Lifesciences India Ltd. Debt to Assets

Balance Sheet >

SMS Lifesciences India Ltd. Cash Flow

Cash Flow >

SMS Lifesciences India Ltd. Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >